BPA for sodium oxybate

Ended Awarded Last action

Contract number
36E79723A0012
Awardee
Awarding agency
Task orders
0

Award facts

Opportunity
  • VA797P12Q0002 Solicitation number
Last date to order 100% complete
IDV ceiling
$38,500,000.00
Award type
Single award
Who can order
Only the awarding agency
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Fixed Price Award Fee

Award details come from SAM.gov/FPDS.

About this IDV

This Blanket Purchase Agreement, awarded on February 7, 2023, by the National Acquisition Center to Hikma Pharmaceuticals USA Inc. (formerly West-Ward Pharmaceuticals) with a ceiling value of $38.5 million, provides a single-award indefinite delivery vehicle for the procurement of sodium oxybate through December 17, 2025. No small business set-aside was utilized for this award. Sodium oxybate, marketed under the brand name XYREM, is a controlled pharmaceutical product used primarily in the treatment of narcolepsy and cataplexy. The contract vehicle operates under the Pharmaceuticals and Drugs (FSS-61-IB) schedule, enabling the National Acquisition Center to issue task orders for this specialized medication to support federal healthcare systems, including military treatment facilities and Veterans Affairs networks. As the original BPA 36E79723A0012 is being canceled in its entirety upon the ultimate completion date, this represents a continuation or renewal of the government's established supply relationship for this critical pharmaceutical product.

Hikma Pharmaceuticals USA Inc., a foreign-owned pharmaceutical manufacturer specializing in generic injectable and non-injectable products, serves as the prime contractor supplying sodium oxybate through this single-award BPA structure. The contractor's existing federal contract portfolio demonstrates substantial capability in delivering controlled and specialized medications to government healthcare systems, with additional significant indefinite delivery vehicles including a $216 million multiple-award Federal Supply Schedule contract with the Department of Veterans Affairs covering pharmaceuticals and hematology-related products. The BPA mechanism allows the National Acquisition Center to establish pricing and terms under which task orders can be issued for sodium oxybate delivery, ensuring consistent supply of this essential medication to federal healthcare providers. This procurement arrangement reflects the government's strategy to secure reliable access to specialized pharmaceutical products through established single-award contracts with qualified manufacturers capable of managing the regulatory and supply chain complexities associated with controlled substances.

Transactions

Action Obligated Date
Legal Contract Cancellation P00005 · This modification is issued to cancel BPA 36E79723A0012 in its entirety on december 17, 2025. $0
Exercise an Option P00004 · This modification is issued to exercise option year 2 on BPA 36E79723A0012. $0
Supplemental Agreement for work within scope P00003 · 2025 PL pricing updates $0
Exercise an Option P00002 · Exercise option year 1 - BPA 36E79723A0012 $0
Supplemental Agreement for work within scope P00001 · 2024 public law pricing updates $0
Original award $0

Quick answers

Who was awarded contract 36E79723A0012?

36E79723A0012 was awarded to Hikma Pharmaceuticals USA Inc. by National Acquisition Center (Headquarters) on February 7, 2023.

How much is contract 36E79723A0012 worth?

36E79723A0012's own ceiling is $38,500,000.

Who can order from contract 36E79723A0012?

36E79723A0012 is a single award blanket purchase agreement. Only the awarding agency can place orders on it.

Is contract 36E79723A0012 under another contract?

Yes. 36E79723A0012 is a blanket purchase agreement under 36F79721D0213, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36E79723A0012 competed?

The extent of competition for 36E79723A0012 was full and open competition. The government received 1 offer.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV